Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 13 medicines
PHARMAC · 6 medicines
CBG-MEB · 4 medicines
AIFA · 3 medicines
AEMPS · 1 medicine
MS · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Clonidine Teva | New Zealand | Tab 25 mcg | Funded | ||
| Catapres | New Zealand | Inj 150 mcg per ml, 1 ml ampoule | Funded | ||
| Catapres | New Zealand | Tab 150 mcg | Funded | ||
| Mylan | New Zealand | Patch 2.5 mg, 100 mcg per day | Funded | ||
| Mylan | New Zealand | Patch 7.5 mg, 300 mcg per day | Funded | ||
| Mylan | New Zealand | Patch 5 mg, 200 mcg per day | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, MS and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
